These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34223079)

  • 1. Mortality attributable to third-generation cephalosporin resistance in Gram-negative bloodstream infections in African hospitals: a multi-site retrospective study.
    Dramowski A; Ong'ayo G; Rehman AM; Whitelaw A; Labi AK; Obeng-Nkrumah N; Ndir A; Magwenzi MT; Onyedibe K; Wolkewitz M; de Kraker MEA; Scott JAG; Aiken AM;
    JAC Antimicrob Resist; 2021 Mar; 3(1):dlaa130. PubMed ID: 34223079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality associated with third-generation cephalosporin resistance in Enterobacterales bloodstream infections at eight sub-Saharan African hospitals (MBIRA): a prospective cohort study.
    Aiken AM; Rehman AM; de Kraker MEA; Madrid L; Kebede M; Labi AK; Obeng-Nkrumah N; Nyamwaya B; Kagucia E; Cocker D; Kawaza K; Lester R; Iregbu KC; Medugu N; Nwajiobi-Princewill PI; Dramowski A; Sonda T; Hemed A; Fwoloshi S; Ojok D; Scott JAG; Whitelaw A;
    Lancet Infect Dis; 2023 Nov; 23(11):1280-1290. PubMed ID: 37454672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality associated with third-generation cephalosporin resistance in Enterobacteriaceae bloodstream infections at one South African hospital.
    Dramowski A; Aiken AM; Rehman AM; Snyman Y; Reuter S; Grundmann H; Scott JAG; de Kraker MEA; Whitelaw A
    J Glob Antimicrob Resist; 2022 Jun; 29():176-184. PubMed ID: 35283332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hospital environment versus carriage: transmission pathways for third-generation cephalosporin-resistant bacteria in blood in neonates in a low-resource country healthcare setting.
    Kovacs D; Silago V; Msanga DR; Mshana SE; Seni J; Oravcova K; Matthews L
    Sci Rep; 2022 May; 12(1):8347. PubMed ID: 35589773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and outcome of bloodstream infections due to third-generation cephalosporin-resistant Enterobacteriaceae in sub-Saharan Africa: a systematic review.
    Lester R; Musicha P; van Ginneken N; Dramowski A; Hamer DH; Garner P; Feasey NA
    J Antimicrob Chemother; 2020 Mar; 75(3):492-507. PubMed ID: 31742611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An International Prospective Cohort Study To Validate 2 Prediction Rules for Infections Caused by Third-generation Cephalosporin-resistant Enterobacterales.
    Deelen JWT; Rottier WC; Giron Ortega JA; Rodriguez-Baño J; Harbarth S; Tacconelli E; Jacobsson G; Zahar JR; van Werkhoven CH; Bonten MJM;
    Clin Infect Dis; 2021 Dec; 73(11):e4475-e4483. PubMed ID: 32640024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a bedside tool to predict the probability of drug-resistant pathogens among hospitalized adult patients with gram-negative infections.
    Lodise TP; Bonine NG; Ye JM; Folse HJ; Gillard P
    BMC Infect Dis; 2019 Aug; 19(1):718. PubMed ID: 31412809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual and population level costs and health-related quality of life outcomes of third-generation cephalosporin resistant bloodstream infection in Blantyre, Malawi.
    Lester R; Mango J; Mallewa J; Jewell CP; Lalloo DA; Feasey NA; Maheswaran H
    PLOS Glob Public Health; 2023; 3(6):e0001589. PubMed ID: 37347746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between the rate of third generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae and antibiotic consumption based on 143 Chinese tertiary hospitals data in 2014.
    Yang P; Chen Y; Jiang S; Shen P; Lu X; Xiao Y
    Eur J Clin Microbiol Infect Dis; 2020 Aug; 39(8):1495-1502. PubMed ID: 32221726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins.
    de Kraker ME; Wolkewitz M; Davey PG; Koller W; Berger J; Nagler J; Icket C; Kalenic S; Horvatic J; Seifert H; Kaasch A; Paniara O; Argyropoulou A; Bompola M; Smyth E; Skally M; Raglio A; Dumpis U; Melbarde Kelmere A; Borg M; Xuereb D; Ghita MC; Noble M; Kolman J; Grabljevec S; Turner D; Lansbury L; Grundmann H
    J Antimicrob Chemother; 2011 Feb; 66(2):398-407. PubMed ID: 21106563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of and risk factor for community-onset third-generation cephalosporin-resistant Escherichia coli bacteremia at a medical center in Taiwan.
    Lin WP; Huang YS; Wang JT; Chen YC; Chang SC
    BMC Infect Dis; 2019 Mar; 19(1):245. PubMed ID: 30866828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the burden of antimicrobial resistance in Malawi: protocol for a prospective observational study of the morbidity, mortality and economic cost of third-generation cephalosporin resistant bloodstream infection.
    Lester R; Maheswaran H; Jewell CP; Lalloo DG; Feasey NA
    Wellcome Open Res; 2020; 5():29. PubMed ID: 32566760
    [No Abstract]   [Full Text] [Related]  

  • 13. Interspecies differences in clinical characteristics and risk factors for third-generation cephalosporin resistance between Escherichia coli and Klebsiella pneumoniae bloodstream infection in patients with liver cirrhosis.
    Ham SY; Jung H; Song KH; Jeong H; Jung J; Moon SM; Park JS; Kim NH; Jang ES; Kim JW; Jeong SH; Kim ES; Kim HB
    Eur J Clin Microbiol Infect Dis; 2022 Dec; 41(12):1459-1465. PubMed ID: 36227508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohort study.
    Stewardson AJ; Allignol A; Beyersmann J; Graves N; Schumacher M; Meyer R; Tacconelli E; De Angelis G; Farina C; Pezzoli F; Bertrand X; Gbaguidi-Haore H; Edgeworth J; Tosas O; Martinez JA; Ayala-Blanco MP; Pan A; Zoncada A; Marwick CA; Nathwani D; Seifert H; Hos N; Hagel S; Pletz M; Harbarth S;
    Euro Surveill; 2016 Aug; 21(33):. PubMed ID: 27562950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is There an Association Between Use of Amoxicillin-Clavulanate and Resistance to Third-Generation Cephalosporins in Klebsiella pneumoniae and Escherichia coli at the Hospital Level?
    Marquet A; Vibet MA; Caillon J; Javaudin F; Chapelet G; Montassier E; Batard E
    Microb Drug Resist; 2018 Sep; 24(7):987-994. PubMed ID: 29489447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Third-generation cephalosporin resistance of community-onset Escherichia coli and Klebsiella pneumoniae bacteremia in a secondary hospital.
    Lee S; Han SW; Kim KW; Song DY; Kwon KT
    Korean J Intern Med; 2014 Jan; 29(1):49-56. PubMed ID: 24574833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bloodstream infections caused by Escherichia coli producing AmpC β-lactamases: epidemiology and clinical features.
    Pascual V; Alonso N; Simó M; Ortiz G; Garcia MC; Xercavins M; Rivera A; Morera MA; Miró E; Espejo E; Navarro F; Gurguí M; Pérez J; Rodríguez-Carballeira M; Garau J; Calbo E
    Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):1997-2003. PubMed ID: 27549108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing incidence and antimicrobial resistance in Escherichia coli bloodstream infections: a multinational population-based cohort study.
    MacKinnon MC; McEwen SA; Pearl DL; Lyytikäinen O; Jacobsson G; Collignon P; Gregson DB; Valiquette L; Laupland KB
    Antimicrob Resist Infect Control; 2021 Sep; 10(1):131. PubMed ID: 34488891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attributable mortality and excess length of stay associated with third-generation cephalosporin-resistant Enterobacterales bloodstream infections: a prospective cohort study in Suva, Fiji.
    Loftus MJ; Young-Sharma TEMW; Lee SJ; Wati S; Badoordeen GZ; Blakeway LV; Byers SMH; Cheng AC; Cooper BS; Cottingham H; Jenney AWJ; Hawkey J; Macesic N; Naidu R; Prasad A; Prasad V; Tudravu L; Vakatawa T; van Gorp E; Wisniewski JA; Rafai E; Peleg AY; Stewardson AJ
    J Glob Antimicrob Resist; 2022 Sep; 30():286-293. PubMed ID: 35738385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attributable mortality of antibiotic resistance in gram-negative infections in the Netherlands: a parallel matched cohort study.
    Rottier WC; Deelen JWT; Caruana G; Buiting AGM; Dorigo-Zetsma JW; Kluytmans JAJW; van der Linden PD; Thijsen SFT; Vlaminckx BJM; Weersink AJL; Ammerlaan HSM; Bonten MJM
    Clin Microbiol Infect; 2020 Jul; ():. PubMed ID: 32698043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.